Frailty Is Associated with an Increased Risk of Major Adverse Cardiac Events in Patients with Stable Claudication
- PMID: 29477684
- PMCID: PMC6014878
- DOI: 10.1016/j.avsg.2017.12.002
Frailty Is Associated with an Increased Risk of Major Adverse Cardiac Events in Patients with Stable Claudication
Abstract
Background: Frailty, a syndrome characterized by decreased physiologic reserves and resistance to stressors, is associated with disability, poor surgical outcomes, and mortality. We evaluated the impact of frailty on cardiovascular disease (CVD) events in peripheral arterial disease (PAD) patients with intermittent claudication.
Methods: We conducted a retrospective review of patients with stable intermittent claudication enrolled in the OMEGA-PAD study between 2010 and 2015. The modified frailty index (mFI) is a retrospectively validated index of frailty derived from the Canadian Study of Health and Aging and was used in this study to categorize frailty as low, medium, or high. Our outcome was time to occurrence of a major adverse cardiac event (MACE), defined as a composite endpoint of myocardial infarction, coronary revascularization, stroke, or CVD-related death. Cox proportional hazards models were used to calculate relative hazards ratio.
Results: There were 129 subjects with a mean age of 67 years, 97% were men, 36% were diabetic, and 33% had known coronary heart disease. When the mFI criteria were applied, 38 subjects were "low" frailty, 72 were "medium" frailty, and 19 were "high" frailty. During the median follow-up period of 34 months (interquartile range: 25-43), 29 subjects experienced a MACE. When compared to the lowest mFI, patients with medium frailty were 2.8 times more likely to have an event (95% confidence interval [CI]: 0.95-8.46, P = 0.06), whereas patients with a high mFI were 4.8 times as likely (95% CI: 1.43-15.8, P = 0.01). In a model adjusted for age, smoking status, and presence of diabetes, those with a medium mFI were 4.3 times more likely to have an event (95% CI: 1.37-13.7, P = 0.01) and those with a high mFI were 9.2 times as likely (95% CI: 2.6-32.4, P = 0.001).
Conclusions: Higher mFI category is associated with a significantly increased risk of MACE in PAD patients with stable claudication. Frailty may serve as a useful adjunct for assessment of overall cardiac risk, particularly as treatment options are being contemplated.
Copyright © 2018 Elsevier Inc. All rights reserved.
Figures


Similar articles
-
Association of frailty index with perioperative mortality and in-hospital morbidity after elective lower extremity bypass.J Vasc Surg. 2019 Mar;69(3):863-874.e1. doi: 10.1016/j.jvs.2018.07.050. Epub 2018 Oct 24. J Vasc Surg. 2019. PMID: 30527215
-
Frailty as a predictor of major adverse cardiac and cerebrovascular events after endovascular aortic aneurysm repair.J Vasc Surg. 2021 Aug;74(2):442-450.e4. doi: 10.1016/j.jvs.2021.01.025. Epub 2021 Feb 4. J Vasc Surg. 2021. PMID: 33548426
-
Modified Frailty Index Can Be Used to Predict Adverse Outcomes and Mortality after Lower Extremity Bypass Surgery.Ann Vasc Surg. 2018 Jan;46:168-177. doi: 10.1016/j.avsg.2017.07.007. Epub 2017 Jul 21. Ann Vasc Surg. 2018. PMID: 28739453
-
A systematic review and meta-analysis of gender differences in long-term mortality and cardiovascular events in peripheral artery disease.J Vasc Surg. 2021 Apr;73(4):1456-1465.e7. doi: 10.1016/j.jvs.2020.09.039. Epub 2020 Nov 6. J Vasc Surg. 2021. PMID: 33161072
-
Frailty and functional outcomes after open and endovascular procedures for patients with peripheral arterial disease: A systematic review.J Vasc Surg. 2020 Jan;71(1):297-306.e1. doi: 10.1016/j.jvs.2018.12.060. Epub 2019 Jul 19. J Vasc Surg. 2020. PMID: 31331651
Cited by
-
The association between frailty and incident cardiovascular disease events in community-dwelling healthy older adults.Am Heart J Plus. 2023 Apr;28:100289. doi: 10.1016/j.ahjo.2023.100289. Epub 2023 Mar 8. Am Heart J Plus. 2023. PMID: 37168270 Free PMC article.
-
Plasma Gut Microbe-Derived Metabolites Associated with Peripheral Artery Disease and Major Adverse Cardiac Events.Microorganisms. 2022 Oct 19;10(10):2065. doi: 10.3390/microorganisms10102065. Microorganisms. 2022. PMID: 36296342 Free PMC article.
-
Association Between Wearable Device-Based Measures of Physical Frailty and Major Adverse Events Following Lower Extremity Revascularization.JAMA Netw Open. 2020 Nov 2;3(11):e2020161. doi: 10.1001/jamanetworkopen.2020.20161. JAMA Netw Open. 2020. PMID: 33211104 Free PMC article.
-
Association of wound, ischemia, and foot infection clinical stage with frailty and malnutrition in chronic limb-threatening ischemia patients undergoing endovascular intervention.Vascular. 2023 Jun;31(3):504-512. doi: 10.1177/17085381221076943. Epub 2022 Feb 28. Vascular. 2023. PMID: 35226573 Free PMC article.
-
C2 Fractures in the Elderly: Single-Center Evaluation of Risk Factors for Mortality.Asian Spine J. 2019 May 14;13(5):746-752. doi: 10.31616/asj.2018.0300. Print 2019 Oct. Asian Spine J. 2019. PMID: 31079430 Free PMC article.
References
-
- Armstrong EJ, Chen DC, Westin GG, Singh S, McCoach CE, Bang H, Yeo KK, Anderson D, Amsterdam EA, Laird JR. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease. Journal of the American Heart Association. 2014;3:e000697. - PMC - PubMed
-
- Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116:1509–26. - PubMed
-
- Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UK, Williams LJ, Mensah GA, Criqui MH. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329–40. - PubMed
-
- Fowkes FG, Aboyans V, Fowkes FJ, McDermott MM, Sampson UK, Criqui MH. Peripheral artery disease: epidemiology and global perspectives. Nature reviews Cardiology. 2017;14:156–170. - PubMed
-
- Khoury H, Lavoie L, Welner S, Folkerts K. The Burden of Major Adverse Cardiac Events and Antiplatelet Prevention in Patients with Coronary or Peripheral Arterial Disease. Cardiovascular therapeutics. 2016;34:115–24. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical